Outcomes of Multiple Runs of Extracorporeal Membrane Oxygenation: An analysis of the Extracorporeal Life Support Registry

体外膜肺氧合 生命维持 医学 体外 回顾性队列研究 队列 呼吸衰竭 死亡率 存活率 急诊医学 外科 重症监护医学 内科学
作者
David S. Cooper,Ravi R. Thiagarajan,Brandon Michael Henry,Jonathan W. Byrnes,Andrew Misfeldt,Jason S. Frischer,Eileen King,Zhiqian Gao,Peter Rycus,Bradley S. Marino
出处
期刊:Journal of Intensive Care Medicine [SAGE Publishing]
卷期号:37 (2): 195-201 被引量:7
标识
DOI:10.1177/0885066620981903
摘要

When patients deteriorate after decannulation from extracorporeal membrane oxygenation (ECMO), a second run of extracorporeal support may be considered. However, repeat cannulation can be difficult and poor outcomes associated with multiple ECMO runs are a concern. The aim of this study was to evaluate outcomes and identify factors associated with survival and mortality in cases of multiple runs of extracorporeal membrane oxygenation.Retrospective cohort analysis of the Extracorporeal Life Support Organization Registry.The Extracorporeal Life Support Organization's registry was queried for neonates, children, and adults receiving 2 or more runs of ECMO during the same hospitalization, for any indication, from 1998 to 2015.1,818 patients from the Extracorporeal Life Support Organization Registry.Of the 1,818 patients, 1,648 underwent 2 runs and 170 underwent 3 or more runs of ECMO. The survival to discharge rate was 36.7% for 2 runs and 29.4% for 3 or more runs. No significant differences in survival were detected in analysis by decade of ECMO run (p = 0.21). Pediatric patients had less mortality than adults (OR: 0.45, 95%CI: 0.24-0.82). Cardiac support on the first run portrayed worse mortality than pulmonary support regardless of final run indication (OR:1.38, 95%CI: 1.09-1.75). Across all age groups, patients receiving pulmonary support on the last run tended to have higher survival rates regardless of support type on the first run. The only first run complication independently predictive of mortality on the final run was renal complications (OR: 1.60, 95%CI: 1.28-1.99).Though the use of multiple runs of ECMO is growing, outcomes remain poor for most cohorts. Survival decreases with each additional run. Patients requiring additional runs for a pulmonary indication should be considered prime candidates. Renal complications on the first run significantly increases the risk of mortality on subsequent runs, and as such, careful consideration should be applied in these cases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
阿锋完成签到 ,获得积分10
1秒前
小杭76应助yjercou采纳,获得10
4秒前
yuyihuii完成签到,获得积分10
4秒前
平安完成签到 ,获得积分10
4秒前
longmad完成签到,获得积分10
4秒前
顾矜应助甜蜜发带采纳,获得10
5秒前
hero_ljw完成签到,获得积分10
5秒前
cchuang完成签到,获得积分10
5秒前
在水一方应助Frank采纳,获得30
5秒前
Cherry完成签到,获得积分10
5秒前
机灵绣连完成签到,获得积分10
6秒前
ysssbq完成签到,获得积分10
7秒前
8秒前
xavier完成签到,获得积分10
8秒前
豪豪完成签到,获得积分10
9秒前
高大莺完成签到 ,获得积分10
9秒前
幽默的妍完成签到 ,获得积分10
9秒前
asdmwhx完成签到,获得积分10
10秒前
安平完成签到,获得积分10
10秒前
晓风完成签到,获得积分10
11秒前
11秒前
回来完成签到,获得积分10
11秒前
田様应助jiyixiao1采纳,获得10
11秒前
sunnyqqz完成签到,获得积分10
12秒前
12秒前
酷波er应助科研通管家采纳,获得10
13秒前
深情安青应助科研通管家采纳,获得10
13秒前
CipherSage应助科研通管家采纳,获得10
13秒前
浮游应助科研通管家采纳,获得30
13秒前
斯文败类应助科研通管家采纳,获得10
13秒前
changping应助科研通管家采纳,获得20
13秒前
ding应助科研通管家采纳,获得10
13秒前
13秒前
貔貅完成签到,获得积分10
14秒前
默默的立辉完成签到,获得积分10
14秒前
sa完成签到 ,获得积分10
14秒前
科研通AI6应助科研通管家采纳,获得10
14秒前
科研通AI5应助科研通管家采纳,获得10
14秒前
田様应助wrj采纳,获得10
14秒前
Akim应助科研通管家采纳,获得10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Pipeline and riser loss of containment 2001 - 2020 (PARLOC 2020) 1000
The Social Work Ethics Casebook: Cases and Commentary (revised 2nd ed.).. Frederic G. Reamer 600
Extreme ultraviolet pellicle cooling by hydrogen gas flow (Conference Presentation) 500
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 500
A Manual for the Identification of Plant Seeds and Fruits : Second revised edition 500
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5175086
求助须知:如何正确求助?哪些是违规求助? 4364428
关于积分的说明 13586706
捐赠科研通 4213528
什么是DOI,文献DOI怎么找? 2311076
邀请新用户注册赠送积分活动 1310068
关于科研通互助平台的介绍 1258103